These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 30788537)
21. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases. Thompson KM; Badizadegan ND Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947 [TBL] [Abstract][Full Text] [Related]
22. Micro-planning in a wide age range measles rubella (MR) campaign using mobile phone app, a case of Kenya, 2016. Ismail A; Tabu C; Onuekwusi I; Otieno SK; Ademba P; Kamau P; Koki B; Ngatia A; Wainaina A; Davis R Pan Afr Med J; 2017; 27(Suppl 3):16. PubMed ID: 29296151 [TBL] [Abstract][Full Text] [Related]
23. A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination. Prausnitz MR; Goodson JL; Rota PA; Orenstein WA Curr Opin Virol; 2020 Apr; 41():68-76. PubMed ID: 32622318 [TBL] [Abstract][Full Text] [Related]
24. Measles-rubella mass immunization campaign in Albania, November 2000. Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917 [TBL] [Abstract][Full Text] [Related]
25. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278 [TBL] [Abstract][Full Text] [Related]
26. [Certain problems with limits of immunity against measles, mumps and rubella]. Magdzik W Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387 [TBL] [Abstract][Full Text] [Related]
28. [The elimination of measles and rubella in Italy]. Adamo G; Sturabotti G; De Soccio P; Prencipe GP; Sciarra I; Baccolini V; Massimi A; Marzuillo C; Iannazzo S; Villari P Ig Sanita Pubbl; 2017; 73(5):429-442. PubMed ID: 29433130 [TBL] [Abstract][Full Text] [Related]
29. Progress Toward Measles and Rubella Elimination - Indonesia, 2013-2022. Chacko S; Kamal M; Hastuti EB; Mildya F; Kelyombar C; Voronika V; Yosephine P; Tandy G; Anisiska D; Karolina S; Dewi LA; Khanal S; Bahl S; Wijayanti F; Merrill RD; Hsu CH; Morales M MMWR Morb Mortal Wkly Rep; 2023 Oct; 72(42):1134-1139. PubMed ID: 37856681 [TBL] [Abstract][Full Text] [Related]
30. [Experience with preventive measles, mumps and rubella vaccination in unified Germany]. Gerike E; Tischer A Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543 [TBL] [Abstract][Full Text] [Related]
31. Serological assessment of measles-rubella vaccination catch-up campaign among university students. Takeuchi J; Goto M; Kawamura T; Hiraide A Pediatr Int; 2014 Jun; 56(3):395-9. PubMed ID: 24417932 [TBL] [Abstract][Full Text] [Related]
32. Toward rubella elimination in Poland: need for supplemental immunization activities, enhanced surveillance, and further integration with measles elimination efforts. Zimmerman L; Rogalska J; Wannemuehler KA; Haponiuk M; Kosek A; Pauch E; Plonska E; Veltze D; Czarkowski MP; Buddh N; Reef S; Stefanoff P J Infect Dis; 2011 Jul; 204 Suppl 1():S389-95. PubMed ID: 21666189 [TBL] [Abstract][Full Text] [Related]
33. [Vaccination status and implementation of recommendations for vaccination with special reference to measles-mumps-rubella vaccination. 1995 program for school entrance]. Ziemer B; Blank K; Hennig R Gesundheitswesen; 1998 May; 60(5):297-300. PubMed ID: 9676011 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh. Uddin MJ; Adhikary G; Ali MW; Ahmed S; Shamsuzzaman M; Odell C; Hashiguchi L; Lim SS; Alam N BMC Infect Dis; 2016 Aug; 16():411. PubMed ID: 27519586 [TBL] [Abstract][Full Text] [Related]
36. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines. Heath TC; Burgess MA; O'Brien ED Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551 [No Abstract] [Full Text] [Related]
37. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study. Bae GR; Choe YJ; Go UY; Kim YI; Lee JK Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654 [TBL] [Abstract][Full Text] [Related]
38. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination. Rainey JJ; Danovaro-Holliday MC; Magloire R; Kananda G; Lee CE; Chamouillet H; Lacapere F; Mung K; Luman ET J Infect Dis; 2011 Sep; 204 Suppl 2():S616-21. PubMed ID: 21954256 [TBL] [Abstract][Full Text] [Related]
39. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96]. Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798 [TBL] [Abstract][Full Text] [Related]
40. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance. Pistol A; Hennessey K; Pitigoi D; Ion-Nedelcu N; Lupulescu E; Walls L; Bellini W; Strebel P J Infect Dis; 2003 May; 187 Suppl 1():S217-22. PubMed ID: 12721916 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]